NCT04876638View on ClinicalTrials.gov

Minocycline for Aneurysmal Subarachnoid Hemorrhage (MASH)

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

December 31, 2027

Study Completion Date

December 30, 2028

Conditions
Aneurysm, RupturedVasospasm, IntracranialDelayed Cerebral IschemiaBlood Brain Barrier Defect
Interventions
DRUG

Minocyclin

10mg/kg minocycline up to 700mg for 4 days following aneurysmal subarachnoid hemorrhage

Trial Locations (1)

90033

University of Southern California Department of Neurosurgery, Los Angeles

All Listed Sponsors
lead

University of Southern California

OTHER